CYP4B1 and liver dysplastic nodule: Wang et al. [59] found that the role of CYP4B1-PS1-001 in the proliferation and fibrosis of mesangial cells as prominent features during early-stage DN could provide a potential therapeutic target and molecular biomarker for the disease.